Clarifies that testosterone therapy is covered treatment under the "New Jersey Menopause Coverage Act."
This bill clarifies that testosterone therapy is covered under New Jersey's existing Menopause Coverage Act for women diagnosed with perimenopause or menopause. It requires health insurance plans to provide testosterone therapy to the same extent as other hormonal treatments, even if the FDA has not specifically approved it for these conditions. The legislation also mandates that insurers provide clear information about covered menopause treatments and includes other services like non-hormonal medications, behavioral health care, pelvic floor physical therapy, and bone health treatments. This change directly affects women in New Jersey who use testosterone therapy for menopausal symptoms and the insurance companies that cover their healthcare.
Bill status
in committee
1 of 4 stages cleared
Introduction
Mar 2026
Committee Review
Floor Vote
Governor
Introduced Mar 10, 2026
Last action Mar 10, 2026
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
1
Key actions
0
Committee
0
Mar 10, 2026
Introduced
Introduced, Referred to Assembly Financial Institutions and Insurance Committee
lower
2 primary · 0 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about A 4642
Scope: NJ
Hi! I can help you understand A 4642. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline